Yasho Industries Ltd

- The company has ongoing capex plans amounting to INR100 crores for FY '26, including INR75 crores for capacity expansion and INR25 crores for R&D. - Debt-to-EBITDA ratio target is to be below 4 by March '26 and comfortably around 2.5x in the long term. - There was a repayment of some debt in the recent quarter; an additional INR9 crores repayment is planned starting November 2025. - No specific mention of new fundraising through equity or additional debt beyond managing and reducing existing debt and funding capex from internal or existing sources was made. - Further capex plans for FY '27 and beyond will be communicated during the April '26 investor call. - Overall, the focus is on debt reduction, improving working capital, and funding expansions via planned capex without explicit mention of raising new external funds currently.

- Planned annual capex for FY '26 is INR 100 crores: - INR 75 crores for capacity expansion at the Pakhajan facility, expected to be commissioned by Jan-Feb 2026, with revenue impact starting FY '27. - INR 25 crores directed towards setting up a state-of-the-art R&D facility to enhance product development and innovation, slated for completion by October 2025. - Capacity expansion at Pakhajan aims to increase utilization from 50%+, with revenue addition expected to be over INR 200 crores from this investment. - No firm capex plan yet for FY '27; potential projects are on the drawing board, with detailed plans to be shared in April 2026. - Focus of capex includes: - Improving existing processes and operational efficiency through R&D. - Developing new chemistries for the industrial segment. - Enhancing market expansion and product innovation capabilities.

- Yasho Industries expects over 40% revenue growth in FY '26, driven primarily by volume increases. - Q1 FY '26 showed 14% YoY growth; volumes grew by 33%, indicating strong operational momentum. - Export revenue is projected to increase from 67% to about 70% of total revenue, with strong demand from Western markets. - Domestic market growth is slower due to local challenges and cheap imports. - Capacity expansion at Pakhajan (INR75 crores capex) will come into revenue from FY '27, targeted to boost output. - Utilization at Pakhajan expected to rise from 50% in Q1 FY '26 to around 70-80% by Q4 FY '26. - Company aims to optimize product mix and increase market share even in subdued pricing. - Long-term plans include better asset utilization, working capital reduction, and a steady growth trajectory.

- Yasho Industries expects over 40% revenue growth in FY '26 driven by volume growth and market share gains, especially in export markets. - EBITDA margins are guided to be maintained between 17% to 19% in FY '26, with no immediate plans to push beyond 19% due to geopolitical uncertainty. - Operational leverage is expected from better capacity utilization, especially post commissioning of INR75 crore capacity expansion in Pakhajan in FY '27. - Debt-to-EBITDA ratio aims to improve to around 2.5x long-term, with planned capex announcements in April '26 supporting growth. - R&D investments (INR25 crore) targeted to improve process efficiency and enable new product chemistry are expected to drive medium to long-term profitability. - Efforts to optimize working capital by reducing inventory days below 150 are expected to enhance cash flow and ROCE, supporting sustainable profit growth.

- The company indicated strong order visibility backing its growth outlook. - Despite global macroeconomic challenges, Yasho Industries delivered its highest-ever quarterly revenue in Q1 FY '26. - Efforts to enhance capacity utilization and customer engagement are underway to support future growth. - No specific numbers or exact current order book/pending orders were disclosed during the call. - The management remains confident of sustained demand and market share gains. - Expansion plans (INR 75 crores capex at Pakhajan) and new product approvals underline robust upcoming business potential. - Overall, the order book appears healthy with positive momentum, supporting the company's guidance of over 40% revenue growth in FY '26.